UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

Scientific reports, 2020-04, Vol.10 (1), p.7073-7073, Article 7073

2020

Link zum Volltext

Verfügbarkeit prüfen

A population-based cohort of young women diagnosed with breast cancer in Geneva, Switzerland

PloS one, 2019-09, Vol.14 (9), p.e0222136-e0222136

2019

Link zum Volltext

Verfügbarkeit prüfen

Location of Mutation in BRCA2 Gene and Survival in Patients with Ovarian Cancer

Clinical cancer research, 2018-01, Vol.24 (2), p.326-333

2018

Link zum Volltext

Verfügbarkeit prüfen

Patterns of genomic change in residual disease after neoadjuvant chemotherapy for estrogen receptor-positive and HER2-negative breast cancer

British journal of cancer, 2021-11, Vol.125 (10), p.1356-1364

2021

Link zum Volltext

Verfügbarkeit prüfen

A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer

Scientific reports, 2023-03, Vol.13 (1), p.3705-3705, Article 3705

2023

Link zum Volltext

Verfügbarkeit prüfen

Influence of chemotherapy on postural control and quality of life in women with gynaecological cancer: a protocol of a prospective observational study

BMJ open, 2022-09, Vol.12 (9), p.e061664

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical utility of 18F-FDG-PET/MR for preoperative breast cancer staging

European radiology, 2016-07, Vol.26 (7), p.2297-2307

2016

Link zum Volltext

Verfügbarkeit prüfen

Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes

British journal of cancer, 2019-04, Vol.120 (9), p.913-921

2019

Link zum Volltext

Verfügbarkeit prüfen

Feasibility, criterion and construct convergent validity of the 2-minute walk test and the 10-meter walk test in an oncological context

Heliyon, 2023-11, Vol.9 (11), p.e22180-e22180, Article e22180

2023

Link zum Volltext

Verfügbarkeit prüfen

Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

Scientific reports, 2020-11, Vol.10 (1), p.19248-19248, Article 19248

2020

Link zum Volltext

Verfügbarkeit prüfen

The Rapidly Changing Treatment Landscape of Systemic Therapy for HER-2 Positive Metastatic Breast Cancer

Healthbook TIMES. Oncology Hematology, 2021-10, Vol.3 (9)

2021

Link zum Volltext

Verfügbarkeit prüfen

Ovarian cancer with high-level focal ERBB2 amplification responds to trastuzumab and pertuzumab

Gynecologic oncology reports, 2021-08, Vol.37, p.100787, Article 100787

2021

Link zum Volltext

Verfügbarkeit prüfen

Towards the first targeted therapy for triple-negative breast cancer: Repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitor

Cancer letters, 2019-05, Vol.449, p.45-55

2019

Link zum Volltext

Verfügbarkeit prüfen

A genetic polymorphism repurposes the G-protein coupled and membrane-associated estrogen receptor GPER to a transcription factor-like molecule promoting paracrine signaling between stroma and breast carcinoma cells

Oncotarget, 2017-07, Vol.8 (29), p.46728-46744

2017

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic precision of breast MRI in prediction of pathological complete response: Is it influenced by the presence of metallic markers?

European journal of radiology, 2022-09, Vol.154, p.110453-110453, Article 110453

2022

Link zum Volltext

Verfügbarkeit prüfen

Hypnotherapy in psycho-oncology : clinical benefits and future prospects

Revue médicale suisse, 2019-05, Vol.15 (651), p.1007

2019

Link zum Volltext

Verfügbarkeit prüfen

Doctor, is it reasonable for me to pursue a physical activity in my condition?

Revue médicale suisse, 2019-05, Vol.15 (651), p.1002

2019

Link zum Volltext

Verfügbarkeit prüfen

Differential impact of tamoxifen and aromatase inhibitors on thrombin generation: the prospective HEMOBREAST cohort

Blood advances, 2022-05, Vol.6 (9), p.2884-2892

2022

Link zum Volltext

Verfügbarkeit prüfen

Role of hormonal manipulations in patients with hormone-sensitive metastatic breast cancer

European journal of cancer (1990), 2011-09, Vol.47, p.S28-S37

2011

Link zum Volltext

Verfügbarkeit prüfen

Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss

Cancer biology & therapy, 2020-03, Vol.21 (3), p.197-202

2020

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy in Urological, Gynecological and Gastrointestinal Cancers - Current Landscape

Praxis (Bern. 1994), 2023-03, Vol.112 (3), p.149

2023

Link zum Volltext

Verfügbarkeit prüfen

Is ketogenic diet effective against cancer ?

Revue médicale suisse, 2023-03, Vol.19 (819), p.576

2023

Link zum Volltext

Verfügbarkeit prüfen

BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients

Breast cancer research and treatment, 2019-04, Vol.174 (3), p.775-783

2019

Link zum Volltext

Verfügbarkeit prüfen

Hematologic toxicities of chemotherapy in breast and ovarian cancer patients carrying BRCA1/BRCA2 germline pathogenic variants. A single center experience and review of the literature

Familial cancer, 2023-07, Vol.22 (3), p.283-289

2023

Link zum Volltext

Verfügbarkeit prüfen

Do patients whose tumor achieved a pathological response relapse at specific sites? A substudy of the EORTC 10994/BIG-1-00 trial

Breast cancer research and treatment, 2018-06, Vol.169 (3), p.497-505

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(46)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Elife
(4)
Revue Médicale Suisse
(4)
Disease Models & Mechanisms
(3)
Scientific Reports
(3)
Breast Cancer Research And Treatment
(2)
British Journal Of Cancer
(2)
Surgical Oncology
(2)
The Breast Journal
(2)
Bioinformatics
(1)
Blood Advances
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

A population-based cohort of young women diagnosed with breast cancer in Geneva, Switzerland

Location of Mutation in BRCA2 Gene and Survival in Patients with Ovarian Cancer

Patterns of genomic change in residual disease after neoadjuvant chemotherapy for estrogen receptor-positive and HER2-negative breast cancer

A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer

Influence of chemotherapy on postural control and quality of life in women with gynaecological cancer: a protocol of a prospective observational study

Clinical utility of 18F-FDG-PET/MR for preoperative breast cancer staging

Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes

Feasibility, criterion and construct convergent validity of the 2-minute walk test and the 10-meter walk test in an oncological context

Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

The Rapidly Changing Treatment Landscape of Systemic Therapy for HER-2 Positive Metastatic Breast Cancer

Ovarian cancer with high-level focal ERBB2 amplification responds to trastuzumab and pertuzumab

Towards the first targeted therapy for triple-negative breast cancer: Repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitor

A genetic polymorphism repurposes the G-protein coupled and membrane-associated estrogen receptor GPER to a transcription factor-like molecule promoting paracrine signaling between stroma and breast carcinoma cells

Diagnostic precision of breast MRI in prediction of pathological complete response: Is it influenced by the presence of metallic markers?

Hypnotherapy in psycho-oncology : clinical benefits and future prospects

Doctor, is it reasonable for me to pursue a physical activity in my condition?

Differential impact of tamoxifen and aromatase inhibitors on thrombin generation: the prospective HEMOBREAST cohort

Role of hormonal manipulations in patients with hormone-sensitive metastatic breast cancer

Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss

Immunotherapy in Urological, Gynecological and Gastrointestinal Cancers - Current Landscape

Is ketogenic diet effective against cancer ?

BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients

Hematologic toxicities of chemotherapy in breast and ovarian cancer patients carrying BRCA1/BRCA2 germline pathogenic variants. A single center experience and review of the literature

Do patients whose tumor achieved a pathological response relapse at specific sites? A substudy of the EORTC 10994/BIG-1-00 trial

Suchergebnisse filtern